Eventide Asset Management - SATSUMA PHARMACEUTICALS INC ownership

SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 31 filers reported holding SATSUMA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of SATSUMA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$28,282,000
+37.5%
983,3820.0%0.62%
-7.7%
Q1 2020$20,562,000
+145.8%
983,382
+131.4%
0.67%
+182.2%
Q4 2019$8,364,000
+31.1%
425,0000.0%0.24%
+11.8%
Q3 2019$6,379,000425,0000.21%
Other shareholders
SATSUMA PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
COMMODORE CAPITAL LP 3,711,286$22,268,0003.58%
NEA Management Company, LLC 3,142,958$18,858,0000.94%
Vivo Capital, LLC 1,232,394$7,394,0000.82%
RA Capital Management 5,914,252$35,486,0000.76%
Nan Fung Group Holdings Ltd 177,900$1,067,0000.68%
Ikarian Capital, LLC 400,000$2,400,0000.48%
SAMLYN CAPITAL, LLC 2,929,195$17,575,0000.33%
EAM Investors, LLC 149,029$894,0000.19%
TPG GP A, LLC 1,885,939$11,316,0000.18%
Ikarian Capital, LLC 136,059$815,0000.16%
View complete list of SATSUMA PHARMACEUTICALS INC shareholders